top
Please input keywords
Order
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hMSLN MC38
Common name
B-MSLN MC38 Catalog number    332181
Aliases

MPF,SMRP

Disease  Colon carcinoma
Organism
Mouse 
Strain  C57BL/6
Tissue types Colon Tissue  Colon

Targeting strategy

from clipboard


Gene targeting strategy for B-hMSLN MC38 cells. The exogenous promoter and full coding sequences of human MSLN was inserted to mouse exon 2 in B-hMSLN MC38 cells.


Protein expression analysis

from clipboard


MSLN expression analysis in B-hMSLN MC38 cells by flow cytometry. Single cell suspensions from B-hMSLN MC38 cultures were stained with species-specific anti-MSLN antibodies. Human MSLN were detected on the surface of B-hMSLN MC38 cells, mouse MSLN were not expressed anymore. The 1-A03 clone of B-hMSLN MC38 cells was used for in vivo experiments.


Tumor growth curve & Body weight changes

from clipboard


Subcutaneous homograft tumor growth of B-hMSLN MC38 cells. B-hMSLN MC38 cells (1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 6-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 × long diameter × short diameter2. As shown in panel A, B-hMSLN MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Tumor growth curve of individual mice


from clipboard

Subcutaneous homograft tumor growth of B-hMSLN MC38 cells. B-hMSLN MC38 cells (1-A03) and wild-type MC38 cells were subcutaneously implanted into C57BL/6N mice (female, 6-week-old, n=8). As shown in panel, B-hMSLN MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Tumor growth curve & Body weight changes


from clipboard


Subcutaneous homograft tumor growth of B-hMSLN MC38 cells. B-hMSLN MC38 cells (1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 14-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 × long diameter × short diameter2. As shown in panel A, B-hMSLN MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Tumor growth curve of individual mice

from clipboard

Subcutaneous homograft tumor growth of B-hMSLN MC38 cells. B-hMSLN MC38 cells (1-A03) and wild-type MC38 cells were subcutaneously implanted into C57BL/6N mice (female, 14-week-old, n=6). As shown in panel, B-hMSLN MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.


Protein expression analysis of tumor cells

from clipboard

Tumor cells were assessed for human MSLN expression by flow cytometry. As shown, human MSLN was expressed on the surface of tumor cells. Therefore, B-hMSLN MC38 cells can be used for in vivo efficacy studies of novel MSLN therapeutics.



B-hMSLN MC38 cells were subcutaneously transplanted into C57BL/6N mice (n=6), and on 34 days post inoculation, tumor cells were harvested and assessed for human MSLN expression by flow cytometry. As shown, human MSLN was expressed on the surface of tumor cells but very low. Therefore, B-hMSLN MC38 cells can be used for in vivo efficacy studies of novel MSLN therapeutics.